Clinical outcomes with olanzapine long-acting injection: impact of the 3-hour observation period on patient satisfaction and well-being

Overview of attention for article published in Neuropsychiatric Disease and Treatment, October 2016

Altmetric Badge

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 3 Dimensions

Readers on

mendeley: 43 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 3 publications that cite this research output.

3

The most recent citing publications are shown below. View all 3 publications that cite this research output on Dimensions.

Consideration of Long-Acting Injectable Antipsychotics for Polypharmacy Regimen in the Treatment of Schizophrenia: Put It on the Table or Not?

Article in Clinical Psychopharmacology and Neuroscience (August 2021)

Long-Acting Injectable Second-Generation Antipsychotics: An Update and Comparison Between Agents

Article in CNS Drugs (March 2018)

Postinjection delirium/sedation syndrome in patients with schizophrenia receiving olanzapine long-acting injection: Results from a large observational study

Article in BJPsych Open (July 2017)